Andromeda Metals Limited (ADN.AX)

Andromeda Metals Limited (ADN.AX) — VMCI valuation read

ADN.AX screens at VMCI 49/100, a 2-point gap below the Basic Materials sector median (50). For a mid-cap Andromeda Metals Limited share, that placement says the multi-pillar composite is richer or lower quality than the typical peer on a like-for-like basis.

ADN.AX has logged no Form 4 insider activity over the trailing 30 days. The tape reads neither bullish nor bearish on insider conviction. The next signal sits with the 10-Q schedule and the analyst calendar.

**Investor frame.** Value: ADN.AX trades at 26.0x earnings, 44% above the Basic Materials median of 18.0x, while EV/EBITDA prints 9.0x against 12.0x for the Basic Materials group. Quality: ROIC of 8.0% trails the Basic Materials median (10.0%) by 2.0pp, the cleanest like-for-like comparison on capital efficiency. Risk: net debt to EBITDA of 1.8x is the rate-sensitivity line to watch, which sets the rate-cycle exposure for Andromeda Metals Limited.

ADN.AX fell 0.7% over the trailing 7 days, with a -2.8% read on a 30-day basis.